Compound ID | 390
Synonym(s): SM-216601 | PZ-601 | SMP-601 | PTZ-601
Class: Beta-lactam
| Agent Type: | Semisynthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | Cell wall synthesis inhibitor |
| Description: | Carbapenem-type; Young CL, Rusca A, Di Stefano AFD, Radicioni M, Binelli D, Loprete L, et al. Safety and multiple dose pharmacokinetics of intravenous PZ-601 (SMP-601): a novel carbapenem. 47th-ICAAC-2007 2007;9-10 |
| Institute where first reported: | Sumitomo Pharmaceuticals (Dainippon Sumitomo Pharma, Japan); Licensed North American rights to Protez Pharmaceuticals, US |
| Year first mentioned: | 2004 |
| Highest development stage: | Phase 2 (NCT00671580) |
| Development status: | Active |
| Reason dropped: | Adverse effects |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/10993211 |
| Guide to Pharmacology: | razupenem |